Literature DB >> 17634438

Mechanical forces in diabetic kidney disease: a trigger for impaired glucose metabolism.

Luigi Gnudi1, Stephen M Thomas, Giancarlo Viberti.   

Abstract

Nephropathy is one of the major microvascular complications of diabetes, and both hemodynamic and metabolic stimuli participate in its development and progression toward ESRD. There is now a greater understanding of the molecular pathways that are activated by high glomerular capillary pressure and hyperglycemia and how they interplay to produce kidney pathology. The observation that overexpression of glucose transporter 1 (GLUT-1) in mesangial cells could induce a "diabetic cellular phenotype" has led to the postulation that the expression of GLUT-1 could be upregulated in glomeruli that are exposed to high pressure. This review suggests a mechanism by which mechanical forces may aggravate a metabolic insult by stimulating excessive cellular glucose uptake. Proposed is the existence of a self-maintaining cycle whereby a hemodynamic stimulus on glomerular cells induces GLUT-1 overexpression followed by greater glucose uptake and activation of intracellular glucose metabolic pathways, resulting in excess TGF-beta1 production. TGF-beta1 in turn, maintains overexpression of GLUT-1, perpetuating a signaling sequence that has, as its ultimate effect, increased extracellular matrix synthesis. This mechanical and metabolic coupling suggests a novel pathophysiologic mechanism of injury in the kidney in diabetes and possibly other glomerular diseases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17634438     DOI: 10.1681/ASN.2006121362

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  35 in total

Review 1.  From fibrosis to sclerosis: mechanisms of glomerulosclerosis in diabetic nephropathy.

Authors:  Ying Qian; Eva Feldman; Subramanian Pennathur; Matthias Kretzler; Frank C Brosius
Journal:  Diabetes       Date:  2008-06       Impact factor: 9.461

2.  Hydraulic pressure inducing renal tubular epithelial-myofibroblast transdifferentiation in vitro.

Authors:  Fei-yan Li; Xi-sheng Xie; Jun-ming Fan; Zi Li; Jiang Wu; Rong Zheng
Journal:  J Zhejiang Univ Sci B       Date:  2009-09       Impact factor: 3.066

3.  Synergistic Interaction of Hypertension and Diabetes in Promoting Kidney Injury and the Role of Endoplasmic Reticulum Stress.

Authors:  Zhen Wang; Jussara M do Carmo; Nicola Aberdein; Xinchun Zhou; Jan M Williams; Alexandre A da Silva; John E Hall
Journal:  Hypertension       Date:  2017-03-27       Impact factor: 10.190

4.  GLUT1 enhances mTOR activity independently of TSC2 and AMPK.

Authors:  Carolyn L Buller; Charles W Heilig; Frank C Brosius
Journal:  Am J Physiol Renal Physiol       Date:  2011-05-25

5.  Glucose dilates renal afferent arterioles via glucose transporter-1.

Authors:  Jie Zhang; Shan Jiang; Jin Wei; Kay-Pong Yip; Lei Wang; En Yin Lai; Ruisheng Liu
Journal:  Am J Physiol Renal Physiol       Date:  2018-03-07

Review 6.  Diabetic kidney disease: from physiology to therapeutics.

Authors:  Carmen Mora-Fernández; Virginia Domínguez-Pimentel; Mercedes Muros de Fuentes; José L Górriz; Alberto Martínez-Castelao; Juan F Navarro-González
Journal:  J Physiol       Date:  2014-06-06       Impact factor: 5.182

Review 7.  A glimpse of various pathogenetic mechanisms of diabetic nephropathy.

Authors:  Yashpal S Kanwar; Lin Sun; Ping Xie; Fu-You Liu; Sheldon Chen
Journal:  Annu Rev Pathol       Date:  2011       Impact factor: 23.472

8.  Simvastatin reverses podocyte injury but not mesangial expansion in early stage type 2 diabetes mellitus.

Authors:  P Wei; P R Grimm; D C Settles; C R Balwanz; B J Padanilam; S C Sansom
Journal:  Ren Fail       Date:  2009       Impact factor: 2.606

9.  Renin angiotensin aldosterone system (RAAS) inhibitors in the prevention of early renal disease in diabetes.

Authors:  Luigi Gnudi; David Goldsmith
Journal:  F1000 Med Rep       Date:  2010-03-15

Review 10.  New insights into the mechanisms of fibrosis and sclerosis in diabetic nephropathy.

Authors:  Frank C Brosius
Journal:  Rev Endocr Metab Disord       Date:  2008-12       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.